Celularity logo

Celularity Share Price Today (NASDAQ: CELU)

Celularity share price is 2.23 & ₹190.44 as on 20 May 2025, 21.17 hrs IST

$2.23

0.06

(2.76%)

Live

View live Celularity share price in Dollar and Rupees. Guide to invest in Celularity stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Celularity, along with analyst recommendations, forecasts, and comprehensive financials.

Celularity share price movements

  • Today's Low: $2.14
    Today's High: $2.23

    Day's Volatility :4.04%

  • 52 Weeks Low: $1.00
    52 Weeks High: $5.22

    52 Weeks Volatility :80.83%

Celularity (CELU) Returns

PeriodCelularity IncSector (Health Care)Index (Russel 2000)
3 Months
12.44%
-8.7%
0.0%
6 Months
-25.68%
-5.9%
0.0%
1 Year
-30.89%
-7.9%
0.0%
3 Years
-96.94%
3.6%
-0.2%

Celularity (CELU) Key Statistics

in dollars & INR

Previous Close
$2.17
Open
$2.16
Today's High
$2.28
Today's Low
$2.14
Market Capitalization
$48.9M
Today's Volume
$64.3K
52 Week High
$5.22
52 Week Low
$1.0007
Revenue TTM
$48.2M
EBITDA
$-31.6M
Earnings Per Share (EPS)
$-2.64
Profit Margin
-72.72%
Quarterly Earnings Growth YOY
-0.61%
Return On Equity TTM
-147.5%

How to invest in Celularity Stock (CELU) from India?

It is very easy for Indian residents to invest directly in Celularity from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Celularity stock in both Indian Rupees (INR) and US Dollars (USD). Search for Celularity or CELU on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Celularity or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Celularity shares which would translate to 0.383 fractional shares of Celularity as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Celularity, in just a few clicks!

Returns in Celularity (CELU) for Indian investors in Rupees

The Celularity stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Celularity investment value today

Current value as on today

₹73,567

Returns

₹26,433

(-26.43%)

Returns from Celularity Stock

₹28,981 (-28.98%)

Dollar Returns

₹2,548 (+2.55%)

Indian investors sentiment towards Celularity (CELU)

43%

Period: Apr 19, 2025 to May 19, 2025. Change in 30 Days versus previous period

Search interest for Celularity Stock from India on INDmoney has increased by 43% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Celularity

  • C V Starr & Co Inc

    3.21%

  • Vanguard Group Inc

    2.10%

  • Geode Capital Management, LLC

    0.55%

  • BlackRock Inc

    0.43%

  • State Street Corp

    0.27%

  • HB Wealth Management, LLC

    0.17%

Analyst Recommendation on Celularity

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Celularity(by analysts ranked 0 to 5 stars)

Analyst Forecast on Celularity Stock (CELU)

What analysts predicted

Upside of 12.11%

Target:

$2.50

Current:

$2.23

Insights on Celularity Stock (Ticker Symbol: CELU)

  • Price Movement

    In the last 7 days, CELU stock has moved up by 16.0%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 9.29M → 18.13M (in $), with an average increase of 24.4% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -13.29M → -26.78M (in $), with an average decrease of 101.5% per quarter
  • CELU vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 94.2% return, outperforming this stock by 125.1%
  • CELU vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 120.6% return, outperforming this stock by 217.7%
  • Price to Sales

    ForCELU every $1 of sales, investors are willing to pay $1.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.0 for every $1 of sales.

Celularity Technicals Summary

Sell

Neutral

Buy

Celularity is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Celularity (CELU) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Celularity Inc logo
42.76%
-25.68%
-30.89%
-96.94%
-78.6%
Regeneron Pharmaceuticals, Inc. logo
5.91%
-20.13%
-39.76%
-12.79%
6.01%
Beone Medicines Ltd logo
1.64%
24.08%
33.65%
72.36%
41.54%
Vertex Pharmaceuticals Incorporated logo
-7.74%
-1.66%
-1.19%
64.18%
54.79%
Alnylam Pharmaceuticals, Inc. logo
25.36%
24.54%
94.2%
125.17%
105.67%

About Celularity

Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBankin. Its lead therapeutic programs include CYNK-001, an allogeneic unmodified natural killer cell that is in Phase I clinical trial for the treatment of acute myeloid leukemia (AML); and APPL-001, a genetically modified placental-derived mesenchymal-like adherent stromal cell for the treatment of Crohn's disease. In addition, the company is developing pExo-001, a human postpartum placenta derived exosome product for the treatment of osteoarthritis. Celularity Inc. produces, sells, and licenses products that are used in surgical and wound care markets, such as Biovance, Biovance 3L, Interfyl, and Centaflex; and collects and stores stem cells from umbilical cords and placentas under the LifebankUSA brand. The company has licensing agreement with Sorrento Therapeutics, Inc. for the development and commercialization of licensed CD19 CAR-T products; research collaboration services agreement with Regeneron Pharmaceuticals, Inc. to support the research of allogeneic cell therapy candidates. Celularity Inc. was founded in 1998 and is based in Florham Park, New Jersey.
Organization
Celularity
Employees
120
CEO
Dr. Robert Joseph Hariri M.D., Ph.D.
Industry
Healthcare

Management People of Celularity

NameTitle
Dr. Robert Joseph Hariri M.D., Ph.D.
Founder, CEO & Chairman
Mr. David C. Beers C.F.A.
Chief Financial Officer
Mr. John R. Haines
Senior EVP, Corporate Secretary, Global Manager & Chief Administrative Officer
Mr. Carlos Ramirez
SVP of Investor Relations
Dr. Stephen A. Brigido D.P.M.
President of Degenerative Diseases
Sharmila Koppisetti M.D.
Senior Vice President of Clinical Dev. Immunology & Drug Safety
Mr. Tim Wilk
Senior Vice President of Technical Operations
Mr. David Jakob Lemus CPA, M.S., MBA
Treasurer

Important FAQs about investing in CELU Stock from India :

Can Indians buy Celularity shares?

Yes, Indians can invest in the Celularity (CELU) from India.

With INDmoney, you can buy Celularity at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Celularity at zero transaction cost.

How can I buy Celularity shares from India?

It is very easy to buy Celularity from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Celularity (CELU) be purchased?

Yes, you can buy fractional shares of Celularity with INDmoney app.

What are the documents required to start investing in Celularity stocks?

To start investing in Celularity, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Celularity share price today?

Celularity share price today stands at $2.23, Open: $2.16 ; Previous Close: $2.17 ; High: $2.23 ; Low: $2.14 ; 52 Week High: $5.22 ; 52 Week Low: $1.00.

The stock opens at $2.16, after a previous close of $2.17. The stock reached a daily high of $2.23 and a low of $2.14, with a 52-week high of $5.22 and a 52-week low of $1.00.

What are today’s High and Low prices of Celularity Stock (CELU)?

Today’s highest price of Celularity (CELU) is $2.23.

Today’s lowest price of Celularity (CELU) is $2.14.

What is the 52 Week High and Low Range of Celularity Stock (CELU)?

  • 52 Week High

    $5.22

  • 52 Week Low

    $1.00

What are the historical returns of Celularity (CELU)?

  • 1 Month Returns

    42.76%

  • 3 Months Returns

    -25.68%

  • 1 Year Returns

    -30.89%

  • 5 Years Returns

    -78.6%

What is today's market capitalisation of Celularity?

Today's market capitalisation of Celularity CELU is 48.9M

Who is the Chief Executive Officer (CEO) of Celularity ?

Dr. Robert Joseph Hariri M.D., Ph.D. is the current Chief Executive Officer (CEO) of Celularity.